PRDX6 and acute respiratory distress syndrome: An important finding in our quest for a pharmacological agent to prevent or treat ALI was that the PLA2 activity (called aiPLA2) of the enzyme peroxiredoxin 6 (Prdx6) is essential for activation of NOX2 [20,21].